Paper36920358
Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials.
Budde H and 2 others. JAMA Psychiatry, 2023. Cited by 10 papers, by iCite.
Cite this record
ConductScience Library. Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials. Papers, record 36920358. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/36920358
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Potential of Control Conditions for Nonspecific Treatment Effects in Noninferiority Trials.
- PubMed
Topics4
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Research Design | Major topic |
| Equivalence Trials as Topic | Major topic |
| Control Groups | Major topic |
| Humans |
Source PubMed
Comments and corrections2
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers | Source |
|---|---|---|---|---|
| Comment in | 36920354 | Potential of Control Conditions for Nonspecific Treatment-Effects in Noninferiority Trials-Reply. | https://conductscience.org/library/papers/36920354 | PubMed |
| Comment on | 36350591 | Mindfulness-Based Stress Reduction vs Escitalopram for the Treatment of Adults With Anxiety Disorders: A Randomized Clinical Trial. | https://conductscience.org/library/papers/36350591 | PubMed |
Cited by6
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 10 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41906162 | Effects of cognitively engaging physical activity on executive function, mental health, and physical fitness in school-age children: a cluster-randomized controlled trial. | BMC Psychol | 2026 | https://conductscience.org/library/papers/41906162 | PubMed |
| 41639791 | Aerobic exercise for depression symptoms in adolescents: a systematic review and dose-response meta-analysis. | BMC Public Health | 2026 | https://conductscience.org/library/papers/41639791 | PubMed |
| 41350316 | Acute 3.5-minute light-intensity exercise enhances executive function and psychological mood in children. | Sci Rep | 2025 | https://conductscience.org/library/papers/41350316 | PubMed |
| 40926883 | Feasibility of combining tDCS with exercise for increasing physical activity in people with depression. | Front Physiol | 2025 | https://conductscience.org/library/papers/40926883 | PubMed |
| 40880927 | The impact of high-intensity exercise on patients with depression: a systematic review and meta-analysis of randomized controlled trials. | Front Public Health | 2025 | https://conductscience.org/library/papers/40880927 | PubMed |
| 40323978 | A 10 years update of effects of exercise on depression disorders-in otherwise healthy adults: A systematic review of meta-analyses and neurobiological mechanisms. | PLoS One | 2025 | https://conductscience.org/library/papers/40323978 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/36920358
GET https://conductscience.org/api/papers/v1/36920358/authors